Literature DB >> 7526932

The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.

C Li1, M Ramjeesingh, E Reyes, T Jensen, X Chang, J M Rommens, C E Bear.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation-regulated Cl- channel. In most mammalian cells, the functional consequences of the most common CF mutation, delta F508-CFTR, cannot be assessed as the mutant protein undergoes biosynthetic arrest. However, function can be studied in the baculovirus-insect cell expression system where delta F508-CFTR does not appear to undergo such arrest. Our results show that phosphorylation-regulated Cl- channel activity of delta F508-CFTR is similar to that of wild-type CFTR. This observation was confirmed in comparative studies of purified delta F508-CFTR and CFTR reconstituted in planar lipid bilayers. Therefore, we suggest that this common mutation does not result in a significant alteration in CFTR function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7526932     DOI: 10.1038/ng0493-311

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  51 in total

1.  What happens to deltaF508 in vivo?

Authors:  M Drumm
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 2.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.

Authors:  Marina S Gelman; Ron R Kopito
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity.

Authors:  Stefania Monterisi; Maria Favia; Lorenzo Guerra; Rosa A Cardone; Domenico Marzulli; Stephan J Reshkin; Valeria Casavola; Manuela Zaccolo
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

4.  The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.

Authors:  Viktoriya Paroder; Juan P Nicola; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2013-05-20       Impact factor: 5.285

5.  Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.

Authors:  Silvia M Kreda; Marcus Mall; April Mengos; Lori Rochelle; James Yankaskas; John R Riordan; Richard C Boucher
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

6.  Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator and immunoglobulin-like repeats of filamin.

Authors:  Laura Smith; Richard C Page; Zhen Xu; Ekta Kohli; Paul Litman; Jay C Nix; Sujay S Ithychanda; Jianmin Liu; Jun Qin; Saurav Misra; Carole M Liedtke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

7.  A posttranslational modification code for CFTR maturation is altered in cystic fibrosis.

Authors:  Sandra Pankow; Casimir Bamberger; John R Yates
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

8.  Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.

Authors:  Tsukasa Okiyoneda; Kazutsune Harada; Motohiro Takeya; Kaori Yamahira; Ikuo Wada; Tsuyoshi Shuto; Mary Ann Suico; Yasuaki Hashimoto; Hirofumi Kai
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

9.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

10.  CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.

Authors:  F Dupuit; N Kälin; S Brézillon; J Hinnrasky; B Tümmler; E Puchelle
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.